The interplay between intestinal bacteria and host metabolism in health and disease: lessons from Drosophila melanogaster

• Main Authors: Adam C. N. Wong, Audrey S. Vanhove, Paula I. Watnick
• Format: Article
• Language: English
• Published: The Company of Biologists 2016-03-01
• Series: Disease Models & Mechanisms
• Subjects: Drosophila melanogaster; Commensal; Metabolism; Microbiota; Pathogen
• Online Access: http://dmm.biologists.org/content/9/3/271
• ISSN: 1754-8403; 1754-8411

All higher organisms negotiate a truce with their commensal microbes and battle pathogenic microbes on a daily basis. Much attention has been given to the role of the innate immune system in controlling intestinal microbes and to the strategies used by intestinal microbes to overcome the host immune response. However, it is becoming increasingly clear that the metabolisms of intestinal microbes and their hosts are linked and that this interaction is equally important for host health and well-being. For instance, an individual's array of commensal microbes can influence their predisposition to chronic metabolic diseases such as diabetes and obesity. A better understanding of host–microbe metabolic interactions is important in defining the molecular bases of these disorders and could potentially lead to new therapeutic avenues. Key advances in this area have been made using Drosophila melanogaster. Here, we review studies that have explored the impact of both commensal and pathogenic intestinal microbes on Drosophila carbohydrate and lipid metabolism. These studies have helped to elucidate the metabolites produced by intestinal microbes, the intestinal receptors that sense these metabolites, and the signaling pathways through which these metabolites manipulate host metabolism. Furthermore, they suggest that targeting microbial metabolism could represent an effective therapeutic strategy for human metabolic diseases and intestinal infection.